PLoS ONE (2014) 9:e107531
doi: 10.3389/fmolb.2022.1016090 Received 18 August 2022 Accepted 15 September 2022 Published 29 September 2022 Volume 9 - 2022 Edited by Ye Sun, Boston Children's Hospital, Harvard Medical School, United States Reviewed by Xudong Wang, Massachusetts General Hospital, Harvard Medical School, United States Xiujuan Shi, Tongji University, China Updates Copyright 2022 Ma, Yang, Zuo and Huang
Trial data shows GLP-1 agonists maintain efficacy when formulations are switched, especially when doses are adjusted based on individual response patterns
Compounded semaglutide from a telehealth clinic costs $200400 per month
Chen, W., and Liu, M
Patients in Kenya, currently paying up to Sh150,000 a month for the diabetes drug Ozempic, could soon access the treatment at a fraction of the cost following the expiry of its patent